HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

dimebolin (dimebon)

structure
Also Known As:
dimebon; PF 01913539; PF 1913539; PF-01913539; PF-1913539; PF01913539; PF1913539; dimebone; latrepirdine; 2,3,4,5-tetrahydro-2,8-dimethyl-5-(2-(6-methyl-3-pyridyl)-ethyl)-1H-pyrid(4,3b)indole
Networked: 48 relevant articles (10 outcomes, 23 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bachurin, Sergey O: 7 articles (01/2013 - 05/2003)
2. Buchman, Vladimir L: 5 articles (01/2013 - 07/2009)
3. Steele, J W: 3 articles (08/2013 - 01/2013)
4. Martins, R N: 3 articles (08/2013 - 01/2013)
5. Gandy, S: 3 articles (08/2013 - 01/2013)
6. Ninkina, Natalia: 3 articles (01/2013 - 07/2009)
7. Bezprozvanny, Ilya: 3 articles (10/2010 - 01/2008)
8. Jordán, Joaquín: 2 articles (01/2015 - 01/2014)
9. Cano-Cuenca, Nieves: 2 articles (01/2015 - 01/2014)
10. Ju, S: 2 articles (08/2013 - 08/2013)

Related Diseases

1. Alzheimer Disease (Alzheimer's Disease)
2. Huntington Disease (Huntington's Disease)
3. TDP-43 Proteinopathies
4. Frontotemporal Lobar Degeneration (Semantic Dementia)
5. Headache (Headaches)

Related Drugs and Biologics

1. dimebolin (dimebon)
2. protein TDP-43 (TDP-43)
3. Methylene Blue (Methylthioninium Chloride)
4. Growth Hormone (Somatotropin)
5. flurizan
6. TNFR-Fc fusion protein (etanercept)
7. quifenadine
8. Synucleins
9. Amyloid (Amyloid Fibrils)
10. Glutamic Acid (Glutamate)

Related Therapies and Procedures

1. Activities of Daily Living (ADL)